SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Coherus BioSciences Q1 EPS $0.480 Misses $0.560 Estimate, Sales $116.180M Miss $119.520M Estimate

Coherus BioSciences (NASDAQ:CHRS) reported quarterly earnings of $0.480 per share which missed the analyst consensus estimate of $0.560 by 14.29 percent. This is a 265.52 percent increase over losses of $(0.290) per

Benzinga · 05/07/2020 21:07

Coherus BioSciences (NASDAQ:CHRS) reported quarterly earnings of $0.480 per share which missed the analyst consensus estimate of $0.560 by 14.29 percent. This is a 265.52 percent increase over losses of $(0.290) per share from the same period last year. The company reported quarterly sales of $116.180 million which missed the analyst consensus estimate of $119.520 million by 2.79 percent. This is a 213.17 percent increase over sales of $37.098 million the same period last year.